Metraipolis › archive › dc_45980b781bd0

Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41212478
DOI
10.1007/s12325-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-08T16:48:46.882Z
SHA-256 of the archived text
ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c
Stable URL of this page
https://metraipolis.com/documento/dc_45980b781bd0

How to cite

Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478 — Europe PMC (en), https://europepmc.org/article/MED/41212478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45980b781bd0 (Metraipolis archive dc_45980b781bd0, sha256 ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c)
BibTeX
@misc{dc45980b781bd0,
  title = {Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41212478},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45980b781bd0; sha256 ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41212478. Agents can read the archived copy with the MCP tool read_document.